A dendrimer that depletes bioavailable copper as a result of its internal make-up displays powerful anticancer activity in mice, and no observable adverse effects.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$99.00 per year
only $8.25 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Tomalia, D. A., Christensen, J. B. & Boas, U. (eds) Dendrimers, Dendrons and Dendritic Polymers (Cambridge Univ. Press, Cambridge, UK, 2012).
Mintzer, M. A. & Grinstaff, M. W. Chem. Soc. Rev.40, 173–190 (2011).
Shao, S. et al. Nat. Biomed. Eng. https://doi.org/10.1038/s41551-017-0130-9 (2017).
Svenson, S. Chem. Soc. Rev.44, 4131–4144 (2015).
Walter, M. V. & Malkoch, M. Chem. Soc. Rev.41, 4593–4609 (2012).
Gupte, A. & Mumper, R. J. Cancer Treat. Rev.35, 32–46 (2009).
Brady, D. C. et al. Nature509, 492–496 (2014).
Starpharma Successful VivaGel® Phase 3 Results and NDA Planned for rBV http://www.starpharma.com/news/328 (7 August 2017).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lyu, Z., Peng, L. Potent drugless dendrimers. Nat Biomed Eng 1, 686–688 (2017). https://doi.org/10.1038/s41551-017-0136-3
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41551-017-0136-3
This article is cited by
-
Nanotechnology-based mRNA vaccines
Nature Reviews Methods Primers (2023)